Literature DB >> 32685032

Quercetin and Isoquercitrin Inhibiting Hepatic Gluconeogenesis Through LKB1-AMPKα Pathway.

L Chen1, T Shen1, C P Zhang1, B L Xu1, Y Y Qiu1, X Y Xie1, Q Wang1, T Lei1.   

Abstract

OBJECTIVE: To observe the impact of quercetin and isoquercitrin on gluconeogenesis in hepatocytes.
METHODS: Mouse primary hepatocytes were cultured with lactic acid and pyruvic acid. After treatment with quercetin and isoquercitrin for 24 hours, the glucose concentration in the culture supernatant was determined. RT-PCR was used to detect the mRNAs of PEPCK, G6Pase, LKB1, and AMPKα. Protein levels of LKB1, AMPKα, and Thr172 phosphorylation were evaluated by Western blot.
RESULTS: The glucose concentration in the gluconeogenesis group (GN) was significantly higher than in the control group (C), but the glucose concentrations in the high level quercetin(group 80Q) and high level isoquercitrin (group 80I) were significantly lower than in the group GN, P<0.01. In the group 80Q, and group 80I, the mRNA levels of PEPCK and LKB1were significantly lower than in the group GN (P<0.01), and the G6Pase mRNA were significantly lower than in the group GN (P<0.05). The protein levels of LKB1 and the phosphorylation of AMPKα Thr172 in the group 80Q, group 40I, and group 80I were higher than in the group GN. The effects of quercetin and isoquercitrin on LKB1 and AMPKα were similar to those of metformin.
CONCLUSIONS: Quercetin and isoquercitrin inhibit gluconeogenesis in hepatocytes, which may be related to the LKB1 upregulation and phosphorylation of AMPKα. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  AMP-activated protein kinase α (AMPKα); gluconeogenesis; isoquercitrin; liver kinase B1 (LKB1); quercetin

Year:  2020        PMID: 32685032      PMCID: PMC7363997          DOI: 10.4183/aeb.2020.9

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  23 in total

1.  α-Glucosidase inhibitory effects of polyphenols from Geranium asphodeloides: Inhibition kinetics and mechanistic insights through in vitro and in silico studies.

Authors:  Gülin Renda; Suat Sari; Burak Barut; Michal Šoral; Tibor Liptaj; Büşra Korkmaz; Arzu Özel; İshak Erik; Didem Şöhretoğlu
Journal:  Bioorg Chem       Date:  2018-09-12       Impact factor: 5.275

2.  Antidiabetic effect of quercetin: A systematic review and meta-analysis of animal studies.

Authors:  Mohammed Bule; Ahmed Abdurahman; Shekoufeh Nikfar; Mohammad Abdollahi; Mohsen Amini
Journal:  Food Chem Toxicol       Date:  2019-02-05       Impact factor: 6.023

3.  Structure characterisation of polysaccharides in vegetable "okra" and evaluation of hypoglycemic activity.

Authors:  Juan Liu; Yupeng Zhao; Qixian Wu; Afiya John; Yueming Jiang; Jiali Yang; Huiling Liu; Bao Yang
Journal:  Food Chem       Date:  2017-09-12       Impact factor: 7.514

4.  Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013.

Authors:  Limin Wang; Pei Gao; Mei Zhang; Zhengjing Huang; Dudan Zhang; Qian Deng; Yichong Li; Zhenping Zhao; Xueying Qin; Danyao Jin; Maigeng Zhou; Xun Tang; Yonghua Hu; Linhong Wang
Journal:  JAMA       Date:  2017-06-27       Impact factor: 56.272

5.  The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways.

Authors:  Jiyun Ahn; Hyunjung Lee; Suna Kim; Jaeho Park; Taeyoul Ha
Journal:  Biochem Biophys Res Commun       Date:  2008-06-27       Impact factor: 3.575

6.  Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.

Authors:  Ming Zhang; Xiaoyan Lv; Jing Li; Zhaojie Meng; Qiujing Wang; WenGuang Chang; Wei Li; Li Chen; Yanjun Liu
Journal:  Mol Cell Endocrinol       Date:  2012-08-16       Impact factor: 4.102

7.  The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes.

Authors:  Hoda M Eid; Abir Nachar; Farah Thong; Gary Sweeney; Pierre S Haddad
Journal:  Pharmacogn Mag       Date:  2015 Jan-Mar       Impact factor: 1.085

8.  The Effect of Abelmoschus Esculentus on Blood Levels of Glucose in Diabetes Mellitus.

Authors:  Maryam Khosrozadeh; Naval Heydari; Malihe Abootalebi
Journal:  Iran J Med Sci       Date:  2016-05

9.  Active subfractions of Abelmoschus esculentus substantially prevent free fatty acid-induced β cell apoptosis via inhibiting dipeptidyl peptidase-4.

Authors:  Chien-Ning Huang; Chau-Jong Wang; Yi-Ju Lee; Chiung-Huei Peng
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

10.  Abelmoschus esculentus subfractions improved nephropathy with regulating dipeptidyl peptidase-4 and type 1 glucagon-like peptide receptor in type 2 diabetic rats.

Authors:  Chiung-Huei Peng; Hsing-Chun Lin; Chih-Li Lin; Chau-Jong Wang; Chien-Ning Huang
Journal:  J Food Drug Anal       Date:  2018-08-14       Impact factor: 6.157

View more
  1 in total

Review 1.  Neuropharmacological Effects of Quercetin: A Literature-Based Review.

Authors:  Md Shahazul Islam; Cristina Quispe; Rajib Hossain; Muhammad Torequl Islam; Ahmed Al-Harrasi; Ahmed Al-Rawahi; Miquel Martorell; Assem Mamurova; Ainur Seilkhan; Nazgul Altybaeva; Bagila Abdullayeva; Anca Oana Docea; Daniela Calina; Javad Sharifi-Rad
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.